By examining the SIRT1/TSC2/mTOR signaling pathway, this study intends to understand the senescence mechanisms in human leukemia K562 cells following treatment with Periplaneta americana extract C-3. In vitro cultures of K562 cells were exposed to varying concentrations of P. americana extract C-3, including 0 (control), 5, 10, 20, 40, 80, and 160 g/mL. The Cell Counting Kit-8 (CCK-8) and flow cytometry techniques were used for the evaluation of the proliferation and cell cycle of the K562 cells. A senescence-associated -galactosidase (SA-gal) staining kit was applied to detect senescent cells exhibiting a positive response. Flow cytometry served as the method for the detection of mitochondrial membrane potential. The relative mRNA level of telomerase reverse transcriptase (TERT) was ascertained via fluorescence quantitative PCR analysis. Fluorescence quantitative PCR and Western blot were respectively employed to ascertain the mRNA and protein levels of SIRT1, TSC2, and mTOR. C-3 was found to significantly inhibit the growth of K562 cells, and the treatment with 80 g/mL C-3 for 72 hours exhibited the strongest inhibitory effect. For subsequent investigations, the 72-hour, 80 gmL⁻¹ C-3 treatment protocol was established as the standard. Compared to the control group, C-3 demonstrated a greater proportion of cells in the G0/G1 phase, a reduced proportion within the S phase, a higher rate of SA,Gal staining positivity, a higher mitochondrial membrane potential, and a lowered expression of TERT mRNA. Particularly, the mRNA expression of SIRT1 and TSC2 was reduced, while the mRNA expression of mTOR was augmented. A decrease in SIRT1 and p-TSC2 protein expression was observed, contrasting with an increase in p-mTOR protein expression. The senescence of K562 cells, as evidenced by the results, was induced by P. americana extract C-3 via the SIRT1/mTOR signaling cascade.
This research aimed to uncover the anti-fatigue effects and the mechanisms involved in the action of Lubian (Cervi Penis et Testis) on mice exhibiting either kidney Yin deficiency or kidney Yang deficiency. Upon completion of a week's adaptive feeding, 88 healthy male Kunming mice were randomly separated into control, kidney Yin deficiency model, kidney Yin deficiency-Panax quinquefolium root, kidney Yin deficiency-Lubian treatment, kidney Yang deficiency model, kidney Yang deficiency-Ginseng root, and kidney Yang deficiency-Lubian treatment groups, with eight mice in each. Dexamethasone acetate was administered orally daily to create the kidney Yin deficiency model, and oral hydrocortisone was used to develop the kidney Yang deficiency model. In parallel, the necessary corresponding medications were supplied. The mice in the control group were provided with the blank reagent. The treatment spanned a period of 14 days. selleck products Measurements of the exhaustive swimming time were completed 30 minutes post-drug administration on day 14. On day fifteen, a sample of blood was obtained from the eyeballs, and the serum fraction was analyzed to measure the levels of lactic acid (LD), blood urea nitrogen (BUN), lactate dehydrogenase (LDH), cyclic adenosine monophosphate (cAMP), and cyclic guanosine monophosphate (cGMP). For the purpose of evaluating both liver glycogen content and the protein expression of phosphoinositide 3-kinase (PI3K) and protein kinase B (Akt), the liver was excised and sectioned. The Lubian treatment groups demonstrated improved body weight (P<0.05), reduced symptoms of kidney Yang deficiency, a decrease in cGMP levels (P<0.001), an increase in the cAMP/cGMP ratio (P<0.001), an extension in exhaustive swimming time (P<0.001), a reduced LD (P<0.001), increased BUN levels (P<0.001), an increased liver glycogen content (P<0.001), and a rise in liver PI3K and Akt protein expression (P<0.05), relative to the kidney Yang deficiency model group. A marked increase in body weight (P<0.001), amelioration of Yin deficiency symptoms, elevation in cGMP levels (P<0.001), a decrease in the cAMP/cGMP ratio (P<0.001), a significant prolongation of exhausted swimming time (P<0.001), lower LD (P<0.001), decreased BUN content (P<0.001), increased liver glycogen content (P<0.001), and enhanced protein expression of PI3K and Akt in the liver (P<0.005 for both) were observed in the kidney Yin deficiency-Lubian treatment groups relative to the kidney Yin deficiency model group. To summarize, Lubian is effective in regulating the imbalances of Yin and Yang, promoting glycogen synthesis through the PI3K-Akt signaling pathway, which consequently mitigates fatigue.
Arctigenin (ARC)'s impact on vascular endothelial damage in pregnancy-induced hypertension (PIH) rats is the subject of this investigation into its mechanism of action. Fifty pregnant SD rats, carrying their fetuses for twelve days, were randomly divided into a control group, a model group, an ARC group, a rapamycin (autophagy inducer) group, and an ARC plus 3-methyladenine (autophagy inhibitor) group, each comprising ten animals. On gestational day 13, rats in experimental groups, excluding the control group, received intraperitoneal injections of nitrosyl-L-arginine methyl ester (50 mg/kg/day) to induce the preimplantation hormonal (PIH) model. At the 15th day of pregnancy, rats belonging to the ARC, RAP, and ARC+3-MA groups were injected intraperitoneally with ARC at 50 mg/kg/day, RAP at 1 mg/kg/day, and a combination of 3-MA (15 mg/kg/day) and ARC (50 mg/kg/day), respectively. The pregnant rats, both in the control and model groups, were injected with the same amount of normal saline intraperitoneally. Following and preceding the intervention, blood pressure and 24-hour urinary protein (24-hour UP) were recorded for the pregnant rats in each respective group. To terminate pregnancies on day 21, Cesarean sections were performed to allow researchers to compare body weight and body length metrics among the groups of fetal rats. Crop biomass The placenta's pathological modifications were scrutinized through the application of hematoxylin-eosin staining. The expression of endothelin-1 (ET-1) and endothelial nitric oxide synthase (eNOS) in the placenta was visualized using immunohistochemical procedures. With the use of suitable kits, serum levels of endothelin-1 (ET-1) and nitric oxide (NO) were measured and recorded. To determine the expression of microtubule-associated protein 1 light chain 3 (LC3), Beclin-1, NOD-like receptor protein 3 (NLRP3), apoptosis-associated speck-like protein with CARD domain (ASC), caspase-1, interleukin (IL)-1, and interleukin-18, immunofluorescence and Western blot assays were performed. Placental reactive oxygen species (ROS) levels were evaluated via fluorescence staining. A comparative assessment of blood pressure and 24-hour urinary protein excretion on day 12 of gestation demonstrated no statistically significant distinctions between groups. On days 15, 19, and 21, the model group displayed higher blood pressure and 24-hour urinary protein levels than the control group, a statistically significant difference (P<0.005). On days 19 and 21, blood pressure and 24-hour urinary protein (UP) levels were demonstrably lower in the ARC and RAP groups compared to the model group (P<0.005), while the ARC+3-MA group exhibited higher values than the ARC group (P<0.005). Histochemistry Compared to the control group, fetal rats in the model group, on day 21, experienced a decrease in body weight and length, an increase in serum ET-1 levels, and a reduction in serum NO levels (P<0.005). The placental tissue's pathology revealed typical damage; LC3-/LC3-, Beclin-1, and eNOS expression was downregulated (P<0.005). Conversely, the expression of ET-1, NLRP3, ASC, caspase-1, IL-1, and IL-18 was upregulated (P<0.005), along with elevated ROS. The ARC and RAP groups, relative to the model group, exhibited increases in fetal rat body weight and length (P<0.005). Serum ET-1 levels decreased, while serum NO levels rose (P<0.005). Pathological damage to placental tissue was also diminished. Expression of LC3-/LC3-II, Beclin-1, and eNOS increased (P<0.005), while expression of ET-1, NLRP3, ASC, caspase-1, IL-1β, and IL-18 decreased (P<0.005). ROS levels were concomitantly lowered. The ARC group's effects on the aforementioned indicators were contrasted by 3-MA, which reversed those effects. In essence, ARC's role is to restrain NLRP3 inflammasome activation and mitigate vascular endothelial harm in PIH rats by activating the autophagy process within their vascular endothelial cells.
Common liver diseases, including non-alcoholic fatty liver disease, cirrhosis, and liver cancer, have been found, by recent studies, to be intrinsically linked to the aging process of the liver (LA). To evaluate the impact and mechanisms by which Dahuang Zhechong Pills (DHZCP), a classic traditional prescription, improves liver injury (LI) with its diverse targets, the present study randomly assigned 24 rats to four groups: a control group, a model group, a DHZCP group, and a vitamin E (VE) group. Each group contained six rats. The LA model in rats was developed through the continuous intraperitoneal delivery of D-galactose (D-gal). The LA model rats' general state was determined by the interplay between their aging phenotype and body weight. An evaluation of LA was carried out by analyzing the pathological characteristics of hepatocyte senescence, hepatic function indicators, the staining patterns of phosphorylated histone family 2A variant (-H2AX), and the expression levels of cell cycle arrest proteins (P21, P53, P16) and the senescence-associated secretory phenotype (SASP) measured within the liver. Hepatic ROS expression and protein levels of PI3K/Akt/FoxO4 pathway components were used to quantify activation of the ROS-mediated PI3K/Akt/FoxO4 signaling pathway. The 12-week DHZCP and VE treatments led to improvements in the characterized aging phenotype, BW, pathological characteristics of hepatocyte senescence, liver function indicators, relative ROS levels, protein expression of p-PI3K, p-Akt, and FoxO4, -H2AX staining, and protein levels of P16, P21, P53, IL-6, and TNF- within the liver. Notably, the effects of DHZCP and VE were similar.